Literature DB >> 22685128

Variation of cardiac troponin I and T measured with sensitive assays in emergency department patients with noncardiac chest pain.

Volkher Scharnhorst1, Krisztina Krasznai, Marcel van 't Veer, Rolf H Michels.   

Abstract

BACKGROUND: New-generation high-sensitivity assays for cardiac troponin have lower detection limits and less imprecision than earlier assays. Reference 99th-percentile cutoff values for these new assays are also lower, leading to higher frequencies of positive test results. When cardiac troponin concentrations are minimally increased, serial testing allows discrimination of myocardial infarction from other causes of increased cardiac troponin. We assessed various measures of short-term variation, including absolute concentration changes, reference change values (RCVs), and indices of individuality (II) for 2 cardiac troponin assays in emergency department (ED) patients.
METHODS: We collected blood from patients presenting with cardiac chest pain upon arrival in the ED and 2, 6, and 12 h later. Cardiac troponin was measured with the high-sensitivity cardiac troponin T (hs-cTnT) assay (Roche Diagnostics) and a sensitive cTnI assay (Siemens Diagnostics). Cardiac troponin results from 67 patients without acute coronary syndrome or stable angina were used in calculating absolute changes in cardiac troponin, RCVs, and II.
RESULTS: The 95th percentiles for absolute change in cardiac troponin were 8.3 ng/L for hs-cTnT and 28 ng/L for cTnI. Within-individual and total CVs were 11% and 14% for hs-cTnT and 18% and 21% for cTnI, respectively. RCVs were 38% (hs-cTnT) and 57% (cTnI). The corresponding log-normal RCVs were +46%/-32% for hs-cTnT and +76%/-43% for cTnI. II values were 0.31 (cTnI) and 0.12 (hs-cTnT).
CONCLUSIONS: The short-term variations and IIs of cardiac troponin were low in ED patients free of ischemic myocardial necrosis. The detection of cardiac troponin variation exceeding reference thresholds can help to identify ED patients with acute myocardial necrosis whereas variation within these limits renders acute coronary syndrome unlikely.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22685128     DOI: 10.1373/clinchem.2011.179903

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

Review 1.  The evolving role of cardiac troponin in the evaluation of cardiac disorders.

Authors:  Paul Anaya; David J Moliterno
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

2.  Evaluation of high sensitive troponin in erectile dysfunction.

Authors:  Alessandra Barassi; Raffaele Pezzilli; Antonio Maria Morselli-Labate; Elena Dozio; Luca Massaccesi; Francesca Ghilardi; Clara Anna Linda Damele; Giovanni Maria Colpi; Gian Vico Melzi d'Eril; Massimiliano Marco Corsi Romanelli
Journal:  Dis Markers       Date:  2015-04-16       Impact factor: 3.434

3.  Establishment of a reference interval for high-sensitivity cardiac troponin I in healthy adults from the Sichuan area.

Authors:  Shunjun Li; Yue Zuo; Wenfang Huang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

4.  Impact of training specificity on exercise-induced cardiac troponin elevation in professional athletes: A pilot study.

Authors:  Johan O Wedin; Nicolena S Nyberg; Anders E Henriksson
Journal:  World J Cardiol       Date:  2020-01-26

5.  A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons.

Authors:  Nir Levi; Gil Moravsky; Yonit Wiener-Well; Tal Hasin; Tatyana Weitsman; Itshak Amsalem; Sarit Bar-Sheshet Itach; Nurit Algur; Ira Lapidus; Ofir Mitz; Michael Glikson
Journal:  Eur J Heart Fail       Date:  2022-09-13       Impact factor: 17.349

Review 6.  High-sensitivity troponin assays: evidence, indications, and reasonable use.

Authors:  Matthew W Sherwood; L Kristin Newby
Journal:  J Am Heart Assoc       Date:  2014-01-27       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.